Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEC110114 in Chronic Hepatitis C (Multiple Ascending Doses)
CTR20192614Phase 2Completed
- Sponsor
- Guangdong Dongyangguang Pharmaceutical
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of encofosbuvir in hepatitis C virus infection, sponsored by Guangdong Dongyangguang Pharmaceutical. Started Dec 2019; status: completed.
02
Drugs
encofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20192614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192614.